Sun Pharma's Q3 profit before tax declines 22% to Rs 1,351.3 crore

The company's India sales posted 13% growth

Sun Pharmaceutical

The country’s largest drug firm Sun Pharma posted a 22 per cent year-on-year (YoY) dip in profit before tax (PBT) for the third quarter of the financial year to Rs

Also Read

Sun Pharma declines nearly 3% as Halol facility gets 8 US FDA observations

Here's why Sun Pharma is betting on Japan when peers are losing interest

Sun Pharma posts Rs 1,433-crore pre-tax profit in Q2, meets estimates

Specialty drugs, domestic growth prospects positives for Sun Pharma stock

Strides Pharma posts Rs 140 crore profit before tax for September quarter

Cognizant beats estimates with 4.2% rise in revenues; profit falls 39%

Aurobindo Pharma Q3 net marginally down at Rs 705 cr, revenue up 12%

Bata India Q3 net profit rises 15% to Rs 118.26 cr, revenue at Rs 830.82 cr

Kalyani Group, Bulgaria's Arsenal sign MoU to manufacture small arms

Cognizant's D'Souza signs off, Bali to join as independent director

Topics : Sun Pharma

First Published: Feb 6 2020 | 9:46 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to